Back

Entrainment of cortical gamma oscillations predicts improved bradykinesia and dyskinesia in Parkinson's disease

Shcherbakova, M.; Cernera, S.; Hahn, A. G.; Little, S.; Starr, P. A.

2026-06-18 neurology
10.64898/2026.06.10.26354720 medRxiv
Show abstract

Background: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is hypothesized to improve motor symptoms in Parkinson's disease (PD) by suppressing pathologically elevated beta activity and promoting "prokinetic" gamma activity in the cortico-basal ganglia-thalamo-cortical loop. Advances in bidirectional DBS devices have revealed that stimulation can modify gamma oscillations via subharmonic entrainment, though entrainment's therapeutic role remains unclear. Objectives: To identify stimulation parameters that entrain motor cortical and STN gamma oscillations in PD at rest and during movement, and examine their association with motor function. Methods: Sensorimotor cortex and STN field potentials were collected using a bidirectional DBS system in four subjects with PD over a range of stimulation amplitudes and frequencies. Entrainment amplitude at half the stimulation frequency was quantified at rest and during a finger-tapping task in the ON-medication state. The presence or absence of entrainment was studied as a physiomarker of motor symptom severity. Results: The amplitude of stimulation-entrained gamma oscillations was non-linearly related to stimulation intensity and frequency and varied by stimulation contact choice. Entrainment amplitude was highest in precentral gyrus and increased with movement. In the ON-medication state, precentral gyrus gamma entrainment was associated with reduced bradykinesia, dyskinesia, and dystonia. Subthalamic gamma entrainment predicted improved dystonia but was a less significant marker for motor benefit than cortical entrainment. Conclusions: Stimulation-entrained gamma oscillations in the motor network are a physiomarker for optimal DBS response in PD, and could have a role in physiology-guided DBS programming, complementing existing strategies based on suppression of basal ganglia beta activity.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Clinical Neurophysiology
56 papers in training set
Top 0.1%
11.7%
2
Movement Disorders
71 papers in training set
Top 0.2%
10.5%
3
npj Parkinson's Disease
105 papers in training set
Top 0.3%
10.5%
4
Brain Communications
166 papers in training set
Top 0.4%
7.8%
5
Brain Stimulation
125 papers in training set
Top 0.3%
6.6%
6
Annals of Neurology
64 papers in training set
Top 0.3%
4.8%
50% of probability mass above
7
Journal of Parkinson's Disease
13 papers in training set
Top 0.1%
4.3%
8
Parkinsonism & Related Disorders
25 papers in training set
Top 0.1%
4.3%
9
Scientific Reports
3612 papers in training set
Top 34%
3.2%
10
Frontiers in Neuroscience
256 papers in training set
Top 2%
2.7%
11
Neurobiology of Disease
148 papers in training set
Top 2%
2.4%
12
Brain
168 papers in training set
Top 2%
2.1%
13
Frontiers in Neurology
102 papers in training set
Top 2%
1.9%
14
Journal of Parkinson’s Disease
12 papers in training set
Top 0.1%
1.9%
15
Journal of Neural Engineering
221 papers in training set
Top 1%
1.7%
16
Journal of NeuroEngineering and Rehabilitation
36 papers in training set
Top 0.5%
1.3%
17
PLOS ONE
5266 papers in training set
Top 56%
1.1%
18
Journal of Neurology
28 papers in training set
Top 0.7%
1.1%
19
NeuroImage: Clinical
144 papers in training set
Top 2%
1.1%
20
Neurorehabilitation and Neural Repair
21 papers in training set
Top 0.4%
1.1%
21
Journal of Neurology, Neurosurgery & Psychiatry
30 papers in training set
Top 0.6%
1.0%
22
Neuromodulation: Technology at the Neural Interface
14 papers in training set
Top 0.3%
1.0%
23
Experimental Neurology
61 papers in training set
Top 1%
1.0%
24
Nature Communications
5641 papers in training set
Top 54%
1.0%
25
European Journal of Neuroscience
189 papers in training set
Top 4%
0.8%
26
Cortex
119 papers in training set
Top 2%
0.8%
27
The Journal of Neuroscience
1025 papers in training set
Top 10%
0.8%